- B2B
- Early StageStartup in initial stages
- Website
- Location
- Company size
- 1-10 people
- Company type
- VC Firm
- Market
Osage University Partners Funding
Investments of Osage University Partners
Merganser Biotech
Atterocor
Applied Genetics Technologies
Cardioxyl Pharmaceuticals
Receptos
Mirna Therapeutics
Aptinyx
Enlibrium
Selecta Biosciences
Precision BioSciences
Kolltan Pharmaceuticals
PMV Pharmaceutcals
Ambiq Micro
Iconic Therapeutics
Cleave Biosciences
Spero Therapeutics
Millendo Therapeutics
Kura Oncology
Exit
Immune Design
Sera Prognostics
Liquid Light Labs
Solarbridge Technologies
Exit
Skytree
Exit
Urjanet
Mc10
Luxtera
Exit
Aerie Pharmaceuticals
Infinio
Kymeta
Tangent Medical Technologies
Avid Radiopharmaceuticals
Exit
CampaignerCRM
Virdante Pharmaceuticals
Corridor pharmaceuticals,
Effector Therapeutics
Clinipace WorldWide
Otonomy